Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

2.
3.
4.

The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.

Grand RJ, Lecane PS, Owen D, Grant ML, Roberts S, Levine AJ, Gallimore PH.

Virology. 1995 Jul 10;210(2):323-34.

5.
6.

Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.

Yew PR, Liu X, Berk AJ.

Genes Dev. 1994 Jan;8(2):190-202.

7.
8.

Physical and functional interactions between PML and MDM2.

Wei X, Yu ZK, Ramalingam A, Grossman SR, Yu JH, Bloch DB, Maki CG.

J Biol Chem. 2003 Aug 1;278(31):29288-97. Epub 2003 May 19.

9.

Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.

Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD, Berger SL.

Oncogene. 1997 Aug 14;15(7):807-16.

10.
11.

The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.

Shimizu H, Burch LR, Smith AJ, Dornan D, Wallace M, Ball KL, Hupp TR.

J Biol Chem. 2002 Aug 9;277(32):28446-58. Epub 2002 Mar 29.

12.

Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.

Liu WL, Midgley C, Stephen C, Saville M, Lane DP.

J Mol Biol. 2001 Nov 2;313(4):711-31.

PMID:
11697899
13.

The p53-mdm-2 autoregulatory feedback loop.

Wu X, Bayle JH, Olson D, Levine AJ.

Genes Dev. 1993 Jul;7(7A):1126-32.

14.

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Momand J, Zambetti GP, Olson DC, George D, Levine AJ.

Cell. 1992 Jun 26;69(7):1237-45.

PMID:
1535557
16.

Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.

Carruth LM, Hardwick JM, Morse BA, Clements JE.

J Virol. 1994 Oct;68(10):6137-46.

17.

Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.

Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M.

J Virol. 1998 Nov;72(11):8510-6.

18.

Mapping of the p53 and mdm-2 interaction domains.

Chen J, Marechal V, Levine AJ.

Mol Cell Biol. 1993 Jul;13(7):4107-14.

19.

The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K.

Schmitz ML, Indorf A, Limbourg FP, Städtler H, Traenckner EB, Baeuerle PA.

Mol Cell Biol. 1996 Aug;16(8):4052-63.

20.

Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein.

Truant R, Xiao H, Ingles CJ, Greenblatt J.

J Biol Chem. 1993 Feb 5;268(4):2284-7.

Items per page

Supplemental Content

Write to the Help Desk